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Hemiconvulsion–hemiplegia–epilepsy syndrome (HHE) is a rare outcome of prolonged 
hemiconvulsion that is followed by diffuse unilateral hemispheric edema, hemiplegia, and 
ultimately hemiatrophy of the affected hemisphere and epilepsy. Here, we describe the 
case of a 3-year-old male with a 1;3 translocation leading to a terminal 1q43q44 deletion 
and a terminal 3p26.1p26.3 duplication that developed HHE after a prolonged febrile 
seizure and discuss the pathogenesis of HHE in the context of the patient’s complex 
genetic background.
Keywords: hemiconvulsion–hemiparesis–epilepsy, 1q43q44 deletion, CoX20, FaM36a, mitochondrial
Case RepoRt
The patient is a 3-year-old male who was found in bed experiencing a tonic–clonic seizure with left 
eye deviation. The duration of the seizure was unknown given that his mother had last seen him at 
least 3–4 h prior to the event. The patient was noted by his mother to be febrile to 102.5°F prior to 
witnessed seizure activity; upon arrival of EMS, his temperature was 100.5°F. He was transported 
to a local hospital, seizures were acutely controlled with lorazepam and levetiracetam, and he was 
transitioned to his home zonisamide regimen. Initially, the patient was assumed to have Todd’s 
paralysis, but when he failed to return to baseline, an MRI was performed on day 2 that showed 
thinned and truncated corpus collosum, diffusely increased T2/FLAIR signal intensity throughout 
the cortices of the left hemispheric gray matter with associated restriction diffusion, left hemispheric 
edema, 6.8 mm midline shift, effacement of the left ventricle, and dilation of the right ventricle. He 
was transferred to our tertiary hospital for neurosurgical management. At the time of admission, 
the patient was minimally responsive and displayed right-sided hemiparesis and gaze deviation, 
increased tone bilaterally, left papilledema, left orbital swelling, and asymmetric pupils who were 
reactive to light. vEEG was significant for diffuse slowing of the L hemisphere without epileptiform 
discharges.
The patient’s past medical history was significant for hypotonia, global developmental delays, 
febrile seizures, breath holding spells, small stature, and patent foramen ovale. The child was born at 
41 weeks to non-consanguinous parents following an uncomplicated delivery. He was found to have 
IUGR, a two vessel cord, ear indentations, branchial cleft cyst, small phallus, and thrombocytopenia. 
The patient developed apnea and staring spells during the first week of life, and MRI performed on 
postnatal day 8 did not reveal structural abnormalities or infarcts. Subsequent magnetic resonance 
angiography (MRA) demonstrated an asymmetrically small right transverse sinus that was patent. 
Karyotype and chromosome microarray analysis were performed, and the patient was found to 
FIGURe 1 | overview of patient’s chromosome 1 deletion. Chromosome 1 ideogram displaying our patient’s 6.9 Mb deletion and the deletion observed in the 
patient described by Gupta et al. (1). The OMIM genes common to both deletions include COX20 (FAM36A), HNRNPU, HNRNPU-AS1, EFCAB2, KIP26B, and 
SMYD3.
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carry an unbalanced 1;3 translocation that results in a 6.9-Mb 
deletion of the distal long arm of chromosome  1 containing 
22 genes and an 8.6-Mb duplication of the distal short arm of 
chromosome 3 that contains 15 genes [46,XY,t(1;3)(q43;p26.1).
arr[hg18] 1q43q44(240,287,612-247,190,999)x1,3p26.3p26.1(35, 
332-8,625,632)x3] (Table  1). Suspecting an association with 
the patient’s known chromosomal abnormality, the literature 
was reviewed, and another patient with similar symptoms and 
a smaller overlapping deletion involving 1q43q44 was identified 
(1) (Figure 1).
Repeat MRI was performed on day 4 and showed worsening 
left-to-right subfalcine herniation anteriorly, patent arterial and 
venous supply, and left-sided diffusion restriction (Figure  2). 
Magnetic resonance spectroscopy (MRS) showed associated 
significant increase in lactate within the left cerebral hemisphere 
with decreased N-acetylaspartic acid, choline, and creatinine. 
A  smaller but elevated lactate signal was observed in the right 
hemisphere. Due to worsening left hemispheric edema, the patient 
was started on intravenous mannitol on the third day of admission 
and transitioned to enteral sodium chloride 24 h later. Head CT 
on the sixth day of admission indicated that hemispheric swell-
ing had stabilized, and repeat MRI/MRS on day 8 was essentially 
unchanged. Laboratory testing on this day revealed decreased 
total and free carnitine levels (14 and 16 nmol/mL, respectively); 
taBLe 1 | Deleted and duplicated oMIM genes resulting from an unbalanced t(1;3)(q43;p26.1).
Gene deletions Gene duplications
Gene Locus oMIM ID Gene Locus oMIM ID
FMN2 1q43 606373 CHL1 3p26.1 607416
GREM2 1q43 608832 CNTN6 3p26-p25 607220
RGS7 1q43|1q23.1 602517 CNTN4 3p26.3 607280
FH 1q42.1 136850 IL5RA 3p26-p24 147851
KMO 1q42-q44 603538 TRNT1 3p25.1 612907
OPN3 1q43 606695 CRBN 3p26.2 607417
CHML 1q43 118825 SETMAR 3p26.1 609834
EXO1 1q42-q43 606063 SUMF1 3p26.1 272200
MAP1LC3C 1q43 609605 ITPR1 3p26.1 117360
CEP170 1q44 613023 EGOT 3p26.1 611662
SDCCAG8 1q43 613524 BHLHE40 3p26 604256
AKT3 1q44 603387 EDEM1 3p26.1 607673
ZBTB18 1q44 608433 GRM7 3p26.1-p25.1 604101
ADSS 1q44 103060 LMCD1 3p26-p24 604859
DESI2 1q44 614638 LINC00312 3p25.3 610485
COX20 (FAM36A) 1q44 614698
HNRNPU 1q44 602869
KIF26B 1q44 614026
SMYD3 1q44 608783
TFB2M 1q44 607055
CNST 1q44 613439
AHCTF1 1q44 610853
The genes common to the deletion in this patient and that reported in Gupta et al. include the OMIM genes highlighted above COX20 (FAM36A), HNRNPU, KIP26B, and SMYD3, as 
well as HNRNPU-AS1 and EFCAB2.
FIGURe 2 | Representative MRI images. (a) T2-weighted axial brain MRI done of this patient at 3 days of age. (B) T2-weighted axial brain MRI done on day 2 of 
the hospital admission showing diffuse increased T2 signal intensity throughout the left hemispheric gray matter. (C) Diffusion-weighted axial brain MRI done on day 
2 of the hospital admission showing diffuse left hemispheric cerebral edema.
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venous lactate was within normal limits (0.8 mmol/L). Given the 
patient’s history, clinical presentation, and MRI findings, he was 
diagnosed with hemiconvulsion–hemiplegia–epilepsy syndrome 
(HHE). The patient was seen in clinic approximately 2 months 
later after the completion of inpatient rehabilitation and displayed 
dense right hemiparesis with the ability to sit alone without sup-
port. His mother reported that his vocalizations and cognitive 
function had returned to baseline, and he was attempting to crawl 
again. At this time, the patient had not experienced a seizure since 
the inciting event.
DIsCUssIoN
Hemiconvulsion–hemiplegia–epilepsy syndrome is a rare out-
come of prolonged focal status epilepticus that typically occurs 
in children under 4 years of age, in the context of febrile illness. 
While the incidence is unknown, it has been reported to have 
declined during the last several decades (2). A 2012 review of all 
published cases by Auvin and colleagues (3) reveal that approxi-
mately 30% of cases have precipitating factors (e.g., cortical 
dysplasia, viral infection, and known genetic polymorphisms), 
while the rest are idiopathic in nature. Clinically, HHE is charac-
terized by prolonged unilateral clonic seizure followed by diffuse 
unilateral hemispheric edema and the development of hemiplegia 
(4). Cytotoxic edema in HHE may be radiographically similar 
to acute ischemic stroke, except that it is not limited to discrete 
vascular territories and is associated with normal MRA. The reso-
lution of hemispheric edema is usually followed by global cerebral 
hemiatrophy, recurrent epilepsy, and persistent hemiplegia. Early 
neuroradiographic findings include increased ipsilateral T2- and 
diffusion-weighted signals, decreased apparent diffusion coef-
ficient (ADC), and, in some cases, midline or temporal lobe her-
niation (3). These findings are associated with increased lactate 
and reduced N-acetyl acetate (NAA) signals on MRS (3, 5). While 
the acute phase of HHE is characterized by ictal discharges on 
EEG, slow waves and spikes followed by higher amplitude delta 
wave slowing may be seen in the affected hemisphere following 
the seizure (3). Several postmortem pathological examinations 
of brain parenchyma from affected individual have been mixed; 
findings include diffuse cortical scarring, edema and necrosis of 
cortical layers III and V, axonal damage, and spongiosis within 
the temporal lobe (6–8).
The pathophysiology of HEE has not been elucidated but 
may involve neuronal injury secondary to excitotoxicity and 
inflammatory changes triggered by prolonged hemiconvulsion 
(3). In this framework, neuronal energy metabolism is perturbed 
during the ictal event (9) and leads to excitoxic cell injury that 
is worsened by the cytokine-mediated inflammatory milieu 
caused by concurrent febrile illness (4). Genetic factors, such as 
channelopathies secondary to mutation within SCN1A (10) or 
CACNA1A (11) or pro-thrombotic states due to the presence of 
factor V Leiden (12), protein S deficiency (12, 13), or the MTHFR 
C677T polymorphism (12), may predispose the patient to HHE 
by increasing the duration of ictal activity, lowering the febrile 
seizure threshold, and/or exacerbating oxidative stress during 
seizure activity. To date, it unknown why seizures are restricted 
to a single hemisphere, although it has been hypothesized that the 
slow kinetics of corpus callosum development may limit seizure 
generalization (14). Another important unanswered question 
is whether if specific infectious agents preferentially predispose 
to HHE. For example, infection with human herpes virus-6 or 
-7 (HHV-6 and HHV-7, respectively) has been linked to febrile 
seizure in the general population (15, 16); yet, there has only been 
one published case of HHV-7 detected in the CSF of an HHE 
patient (17).
For this patient, cytogenetic analysis revealed a 1q43q44 dele-
tion and a 3p26.1p26.3 duplication. Analysis of the deleted por-
tion reveals 22 missing genes on chromosome 1 (Table 1), several 
of which appear to be medically relevant. AKT3, which codes for a 
serine–threonine kinase that is active during brain development, 
has been associated with microcephaly, while abnormalities of the 
corpus collosum may involve ZBTB18 (ZNF238), whose product is 
a C2H2-type zinc finger protein that is expressed during embryo-
genesis and functions as a transcriptional repressor (18). Analysis 
of the duplication reveals three doses of 15 genes (Table 1). 3p26 
duplications have not been widely described in the literature and 
are generally not associated with seizure. However, based on a 
single patient with developmental disability and epilepsy, as well 
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as a 3p26.3 duplication that includes the CHL1 gene that codes 
for neural cell adhesion molecule L1-like protein, it has been pro-
posed that this gene is a dosage sensitive one that may predispose 
to abnormal cognitive development (18).
Only five 1q44 deleted genes (Table 1) are the same in our 
patient and the patient with HHE reported by Gupta et al. (1), 
and only two genes, COX20 (FAM36A) and HNRNPU, have 
been linked to intellectual disability and epilepsy (18, 19). 
HNRNPU codes for heterogeneous nuclear ribonucleopro-
tein U, which is a ribosomal protein involved in pre-mRNA 
processing during development (18). The FAM36A protein, a 
human ortholog of COX20, facilitates assembly of cytochrome 
c oxidase (COX; Complex IV of the electron transport chain), 
and mutant FAM36A can result in decreased COX expression 
in patient fibroblasts and may limit mitochondrial capacity for 
oxidative phosphorylation (20, 21). Given the role of COX20 
in proper cellular expression of COX and the observation that 
mitochondrial encephalopathy, lactic acidosis, and strokes 
(MELAS) is noted for producing rapid onset of MRI signal 
changes associated with cytotoxic edema (e.g., decreased 
ADC) without a vascular distribution like the changes seen 
in our patient, it is possible that mitochondrial dysfunction 
related to COX20 deletion may have exacerbated the patient’s 
symptoms. Metabolic workup during admission, however, was 
equivocal, and the patient’s presentation likely had a multifac-
torial etiology.
Data from recent sequencing and copy number variation stud-
ies suggest that heterozygous loss of any one of the five OMIM 
genes deleted in both our patient and the patient described by 
Gupta et al. is not sufficient to cause HHE. In each case, multiple 
sequence variants likely to result in loss of function (i.e., nonsense, 
frameshift, or splice site changes) were identified in the Exome 
Aggregation Consortium (ExAC) database. With the exception 
of KIF26B and SMYD3, no exon containing deletions involving 
these genes individually or en masse were identified in either 
the Children’s Hospital of Philadelphia (CHOP) database or the 
Database of Genomic Variants (DGV) for benign copy number 
variation. While these data suggest that heterozygous loss of any 
one of these genes is compatible with normal development, it is 
conceivable that haploinsufficiency may contribute to the devel-
opment of HHE, possibly in conjunction with sequence and/or 
copy number variants located within the complementary genes 
on the non-deleted homolog or elsewhere within the genome. 
Further studies, including obtaining a muscle biopsy to assay 
COX function and sequencing non-deleted genomic regions 
on the normal chromosome 1 homolog for deleterious muta-
tions, will be necessary to elucidate the etiology of this patient’s 
presentation.
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